Skip to main content
Premium Trial:

Request an Annual Quote

Waters Q2 Organic Sales Grow 8 Percent, Though Profit Slides 10 Percent

NEW YORK, July 26 (GenomeWeb News) - Waters today said that second-quarter sales increased around 8 percent organically atop increasing R&D spending and a 10-percent slide in net profits.

 

Still, the company's stock was up more than 9 percent, or $3.80, at $44.50 in heavy trading Tuesday afternoon because the profit beat analysts' consensus estimate.

 

Total sales for the period ended July 2 increased 9 percent to $284.6 million from $260.5 million year over year, Waters said. Approximately 1 percent of the growth was the result of favorable foreign-currency exchange rates.

 

R&D spending in the period increased around 5 percent to $16.5 million from $15.7 million in the year-ago quarter.

 

Net income, however, slid almost 10 percent to $54 million, or $.47 per basic share, from $59.8 million, or $.50 per basic share, year over year.

 

Waters said it had around $615 million in cash and equivalents as of July 2.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.